Notably, DBI was associated with an immune landscape potentially indicative of enhanced anti-tumor responses, characterized by inverse correlations with Tregs and MDSCs, alongside positive associations with activated CD8+ and CD4+ T cells. Here, CD8A is linked to neoplasm.